Surgical Theater’s SNAP Gets FDA Nod

Ohio-based company Surgical Theater has confirmed that it has received clearance from the US Food and Drug Administration to market its Surgical Navigation Advanced Platform (SNAP) for neurosurgical applications. SNAP combines flight simulation technology with advanced CT/MRI imaging and can be used in brain surgeries. The system can be interconnected with operating room navigation devices in order to receive advanced visualization of tools and the anatomy of the brain. Surgeons can use SNAP to fly through the patient’s virtually reconstructed 3D brain, thereby preparing a safe and effective approach when removing tumors and repairing vascular defects.

Surgeons can also see what is behind individual anatomical structures, such as vascular networks, by making them semi-transparent and the system can also be used to test out various execution scenarios before a real scalpel is used.

“We are extremely excited to expand our offerings beyond planning and rehearsing surgeries outside the OR. The SNAP, our advanced imaging platform, allows us to connect to the operating room navigation system and become a part of the surgery as its performed, enabling a surgeon and OR team to achieve their goal of delivering the best care and outcome for the patient. We are witnessing strong anticipation from the medical community about this new technology, with multiple pre-orders for the SNAP already placed from hospitals across the country”, Surgical Theater CEO Moty Avisar said.



Source-Medindia